ASEP Medical Holdings (ASEP Medical Holdings) Cash-to-Debt : 3.20 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is ASEP Medical Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. ASEP Medical Holdings's cash to debt ratio for the quarter that ended in Dec. 2023 was 3.20.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, ASEP Medical Holdings could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for ASEP Medical Holdings's Cash-to-Debt or its related term are showing as below:

SEPSF' s Cash-to-Debt Range Over the Past 10 Years
Min: 3.25 Med: No Debt Max: No Debt
Current: 3.25

During the past 3 years, ASEP Medical Holdings's highest Cash to Debt Ratio was No Debt. The lowest was 3.25. And the median was No Debt.

SEPSF's Cash-to-Debt is ranked worse than
60.47% of 1538 companies
in the Biotechnology industry
Industry Median: 6.485 vs SEPSF: 3.25

ASEP Medical Holdings Cash-to-Debt Historical Data

The historical data trend for ASEP Medical Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

ASEP Medical Holdings Cash-to-Debt Chart

ASEP Medical Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Cash-to-Debt

No Debt

3.20

ASEP Medical Holdings Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial							No Debt	No Debt	No Debt	No Debt	3.20

Competitive Comparison of ASEP Medical Holdings's Cash-to-Debt

For the Biotechnology subindustry, ASEP Medical Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ASEP Medical Holdings's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where ASEP Medical Holdings's Cash-to-Debt falls into.

ASEP Medical Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

ASEP Medical Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.048	/	(0.015	+	0)
	=	3.20

ASEP Medical Holdings's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.048	/	(0.015	+	0)
	=	3.20

ASEP Medical Holdings (OTCPK:SEPSF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

ASEP Medical Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of ASEP Medical Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ASEP Medical Holdings (ASEP Medical Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ASEP Medical Holdings Inc (OTCPK:SEPSF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

JJ8:Germany ASEP:Canada

Address

730 View Street, Suite 420, Victoria, BC, CAN, V8W 3Y7

Website

https://www.asepmedical.com

ASEP Medical Holdings Inc is a biotechnology firm pursuing the commercialization of broad-spectrum peptide technology. The Company is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine and is engaged in the business of acquiring research and development assets, technology, or businesses in life sciences and medical diagnostics.